FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

788331007: Product containing polatuzumab vedotin in parenteral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3779942015 Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3779943013 Polatuzumab vedotin-containing product in parenteral dose form en Synonym Active Entire term case insensitive SNOMED CT core module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Is a Product manufactured as parenteral dose form true Inferred relationship Existential restriction modifier
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Has active ingredient Polatuzumab vedotin true Inferred relationship Existential restriction modifier 1
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form true Inferred relationship Existential restriction modifier
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Is a Product containing polatuzumab vedotin (medicinal product) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only polatuzumab vedotin in parenteral dose form (medicinal product form) Is a True Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start